JPH0439316B2 - - Google Patents
Info
- Publication number
- JPH0439316B2 JPH0439316B2 JP14110685A JP14110685A JPH0439316B2 JP H0439316 B2 JPH0439316 B2 JP H0439316B2 JP 14110685 A JP14110685 A JP 14110685A JP 14110685 A JP14110685 A JP 14110685A JP H0439316 B2 JPH0439316 B2 JP H0439316B2
- Authority
- JP
- Japan
- Prior art keywords
- amino acids
- amino acid
- strain
- carbamoyl
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000001580 bacterial effect Effects 0.000 claims description 19
- 150000001469 hydantoins Chemical class 0.000 claims description 16
- 150000008575 L-amino acids Chemical class 0.000 claims description 14
- 241000186073 Arthrobacter sp. Species 0.000 claims description 12
- -1 N-carbamoyl amino Chemical class 0.000 claims description 9
- 241000186063 Arthrobacter Species 0.000 claims description 4
- 238000011160 research Methods 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 18
- 244000005700 microbiome Species 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 229940091173 hydantoin Drugs 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229960004452 methionine Drugs 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- QYASYXWODYQOFU-UHFFFAOYSA-N 5-(1h-indol-2-ylmethyl)imidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1CC1=CC2=CC=CC=C2N1 QYASYXWODYQOFU-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- DEWDMTSMCKXBNP-BYPYZUCNSA-N N-carbamoyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(N)=O DEWDMTSMCKXBNP-BYPYZUCNSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- PNLKYZVGQWCHBH-MRVPVSSYSA-N (2r)-2-(carbamoylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound NC(=O)N[C@@H](C(O)=O)CC1=CC=C(O)C=C1 PNLKYZVGQWCHBH-MRVPVSSYSA-N 0.000 description 1
- NWLXJVDJMARXSP-UHFFFAOYSA-N 2-(carbamoylamino)-3-(1h-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(CC(NC(=O)N)C(O)=O)=CNC2=C1 NWLXJVDJMARXSP-UHFFFAOYSA-N 0.000 description 1
- DEWDMTSMCKXBNP-UHFFFAOYSA-N 2-(carbamoylamino)-4-methylsulfanylbutanoic acid Chemical compound CSCCC(C(O)=O)NC(N)=O DEWDMTSMCKXBNP-UHFFFAOYSA-N 0.000 description 1
- WLRZLHCGXUHRIG-UHFFFAOYSA-N 5-(2-methylpropyl)imidazolidine-2,4-dione Chemical compound CC(C)CC1NC(=O)NC1=O WLRZLHCGXUHRIG-UHFFFAOYSA-N 0.000 description 1
- ZXYPMGRKRLXJHZ-UHFFFAOYSA-N 5-[(4-hydroxy-3-methoxyphenyl)methyl]imidazolidine-2,4-dione Chemical compound C1=C(O)C(OC)=CC(CC2C(NC(=O)N2)=O)=C1 ZXYPMGRKRLXJHZ-UHFFFAOYSA-N 0.000 description 1
- GLLIXWMNULCIKR-UHFFFAOYSA-N 5-[(4-hydroxyphenyl)methyl]imidazolidine-2,4-dione Chemical compound C1=CC(O)=CC=C1CC1C(=O)NC(=O)N1 GLLIXWMNULCIKR-UHFFFAOYSA-N 0.000 description 1
- PBNUQCWZHRMSMS-UHFFFAOYSA-N 5-propan-2-ylimidazolidine-2,4-dione Chemical compound CC(C)C1NC(=O)NC1=O PBNUQCWZHRMSMS-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- DEWDMTSMCKXBNP-SCSAIBSYSA-N N-carbamoyl-D-methionine Chemical compound CSCC[C@H](C(O)=O)NC(N)=O DEWDMTSMCKXBNP-SCSAIBSYSA-N 0.000 description 1
- JDXMIYHOSFNZKO-SCSAIBSYSA-N N-carbamoyl-D-valine Chemical compound CC(C)[C@H](C(O)=O)NC(N)=O JDXMIYHOSFNZKO-SCSAIBSYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 229940011182 cobalt acetate Drugs 0.000 description 1
- QAHREYKOYSIQPH-UHFFFAOYSA-L cobalt(II) acetate Chemical compound [Co+2].CC([O-])=O.CC([O-])=O QAHREYKOYSIQPH-UHFFFAOYSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- IPWQOZCSQLTKOI-QMMMGPOBSA-N d-[(amino)carbonyl]phenylalanine Chemical compound NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IPWQOZCSQLTKOI-QMMMGPOBSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
〔産業上の利用分野〕
本発明はアルスロバクター(Arthrobacter)
属に属し、5置換ヒダントイン及びN−カルバモ
イルアミノ酸を対応するそれぞれのL−アミノ酸
に転換する能力を有する新規な微生物に関するも
のである。
なお、本発明において、特に断わらない限り5
置換ヒダントイン及びN−カルバモイルアミノ酸
なる化合物名は、各々D体、L体、DL体の総称
を意味する。
〔従来の技術及び問題点〕
従来、DL−5置換ヒダントイン類を酵素的に
L−アミノ酸に転換する方法については、特公昭
42−13850号以降多くの特許出願がなされており、
特に芳香属アミノ酸の製造方法としては、フラボ
バクテリウム アミノゲネス(Flavpbacterium
aminogenes)FERM−3133及びその変異株
FERM−3134,FERM−3135を5置換ヒダント
インに作用させる方法が知られている。
またL−N−カルバモイルアミノ酸を酵素的に
L−アミノ酸に転換する方法としては、L−又は
DL−N−カルバモイルメチオニンにコリネバク
テリウムセペドニカム(Corynebacterium
sepedonicam)IFO3306等を作用させて、含まれ
るL−N−カルバモイルメチオニンをL−メチオ
ニンに転換する方法が知られている(特公昭55−
29678号)。しかし、この方法によつて転換するこ
とができるのはL体のみであつてD体をL−メチ
オニンに転換することはできない。
更にまた、従来の酵素法によるL−アミノ酸の
製造法では、5置換ヒダントインを原料とする場
合とN−カルバモイルアミノ酸を原料とする場合
とでは、各々別種の微生物を使用する必要があ
り、5置換ヒダントインとN−カルバモイルアミ
ノ酸の両方に作用し、対応するそれぞれのL−ア
ミノ酸に転換しうる微生物は見出されていなかつ
た。
従つて、DL−5置換ヒダントイン類を原料と
する場合には、その原料の製造の際に副生した
DL−N−カルバモイルアミノ酸を除去する必要
があり、またDL−N−カルバモイルアミノ酸を
原料とする場合にはD−N−カルバモイルアミノ
酸が反応系に混入するのを防止する措置又は反応
終了後残存するD−N−カルバモイルアミノ酸を
分取、ラセミ化するための煩雑な工程を採らざる
得なかつた。更に、DL−N−カルバモイルアミ
ノ酸を水溶性塩として用いれば反応液濃度を高く
できるため反応を有利に行ない得るはずである
が、D体のN−カルバモイルアミノ酸に作用して
L−アミノ酸に転換し得る微生物がなく操作の単
純化は不可能であつた。
〔問題点を解決するための手段〕
本発明者らは、5置換ヒダントイン類の微生物
による分解機作について研究中、発明者等が土壌
中より新たに分離した微生物がヒダントイン化合
物を開裂し、アミノ酸を生成する際にL−N−カ
ルバモイルアミノ酸とD−N−カルバモイルアミ
ノ酸を生成すること、そして逐次的に生成してく
るアミノ酸がL体であることから、この微生物が
従来知られていない能力を有する新規微生物であ
ることを見出し、別途出願した。
この微生物は、アルスロバクター属に属し、5
置換ヒダントイン及びN−カルバモイルアミノ酸
を対応するそれぞれのL−アミノ酸に転換する能
力を有する新菌種アルスロバクター エスピー
(Arthrobacter sp.)DP−B−1001(微工研菌寄
第8190号)である。
本発明の微生物は、このDP−B−1001株から
誘導された変異株であつて、DP−B−1001株と
同様の能力を有する。
すなわち本発明は、アルスロバクター属に属
し、5置換ヒダントイン及びN−カルバモイルア
ミノ酸を対応するそれぞれのL−アミノ酸に転換
する能力を有する新菌種アルスロバクター エス
ピー(Arthrobacter sp.)DP−B−1002(微工研
菌寄第8191号)である。
次に、アルスロバクター エスピー DP−B
−1002の菌学的性質を同DP−B−1001のそれと
共に示す。
[Industrial Application Field] The present invention relates to Arthrobacter
The present invention relates to a novel microorganism belonging to the genus A. In addition, in the present invention, unless otherwise specified, 5
The compound names substituted hydantoin and N-carbamoyl amino acid collectively refer to D-form, L-form, and DL-form, respectively. [Prior art and problems] Conventionally, a method for enzymatically converting DL-5 substituted hydantoins into L-amino acids was disclosed in
Many patent applications have been filed since No. 42-13850.
In particular, as a method for producing aromatic amino acids, Flavobacterium aminogenes (Flavpbacterium
aminogenes) FERM-3133 and its mutants
A method is known in which FERM-3134 and FERM-3135 act on 5-substituted hydantoin. In addition, as a method for enzymatically converting L-N-carbamoyl amino acid to L-amino acid, L- or
Corynebacterium cepedonicum (DL-N-carbamoylmethionine)
There is a known method of converting the L-N-carbamoylmethionine contained in L-methionine into L-methionine by reacting L-N-carbamoylmethionine with IFO3306 etc.
No. 29678). However, only the L-form can be converted by this method, and the D-form cannot be converted to L-methionine. Furthermore, in the conventional enzymatic method for producing L-amino acids, it is necessary to use different types of microorganisms when using a 5-substituted hydantoin as a raw material and when using an N-carbamoyl amino acid as a raw material. No microorganism has been found that can act on both hydantoin and N-carbamoyl amino acid and convert them into the corresponding L-amino acids. Therefore, when using DL-5-substituted hydantoins as a raw material, by-products during the production of the raw material
It is necessary to remove DL-N-carbamoyl amino acid, and when DL-N-carbamoyl amino acid is used as a raw material, measures must be taken to prevent DL-N-carbamoyl amino acid from being mixed into the reaction system, or if it remains after the reaction is completed. It was necessary to take complicated steps to separate and racemize the DN-carbamoyl amino acid. Furthermore, if DL-N-carbamoyl amino acid is used as a water-soluble salt, the concentration of the reaction solution can be increased and the reaction should be carried out advantageously. Since there were no microorganisms to obtain, it was impossible to simplify the procedure. [Means for Solving the Problems] While the present inventors were researching the decomposition mechanism of penta-substituted hydantoins by microorganisms, the microorganisms newly isolated by the inventors from soil cleaved hydantoin compounds and produced amino acids. When producing L-N-carbamoyl amino acid and D-N-carbamoyl amino acid, and the amino acids that are sequentially produced are L-amino acids, this microorganism has a previously unknown ability. We discovered that this is a new microorganism with the following characteristics, and filed a separate application. This microorganism belongs to the genus Arthrobacter, and
A new bacterial species Arthrobacter sp. DP-B-1001 (Feikoken Bibori No. 8190) has the ability to convert substituted hydantoins and N-carbamoyl amino acids into their respective L-amino acids. . The microorganism of the present invention is a mutant strain derived from this DP-B-1001 strain, and has the same ability as the DP-B-1001 strain. That is, the present invention relates to a new bacterial species, Arthrobacter sp. DP-B-, which belongs to the genus Arthrobacter and has the ability to convert 5-substituted hydantoins and N-carbamoyl amino acids into their corresponding L-amino acids. 1002 (Fiber Engineering Research Institute No. 8191). Next, Arthrobacter sp. DP-B
The mycological properties of -1002 are shown together with those of DP-B-1001.
【表】【table】
【表】【table】
【表】【table】
本発明のアルスロバクター エスピー DP−
B−1002は、後記試験例に示す如く5置換ヒダン
トイン及びN−カルバモイルアミノ酸をD体、L
体、DL体の如何を問わず対応するそれぞれのL
−アミノ酸に転換する作用を有する。
〔発明の効果〕
本発明の新規微生物は叙上の如き能力を有する
ため、これをL−アミノ酸の製造に用いれば、そ
の生産性の飛躍的な向上を図ることができる。す
なわち、
(1) 従来、適当な微生物がなく使用し得なかつた
D−N−カルバモイルアミノ酸をも対応するL
−アミノ酸製造の出発原料にできる。
(2) 化学的に5置換ヒダントインを製造する際に
副生するDL−N−カルバモイルアミノ酸を反
応系から除去する必要がないため、工業的に容
易かつ安価に得られるDL−5置換ヒダントイ
ンとDL−N−カルバモイルアミノ酸の混合物
から一段の反応で定量的にL−アミノ酸を製造
することができる。それ故、従来のDL−5置
換ヒダントイン類を出発原料にするL−アミノ
酸製造工程に必要であつたDL−5置換ヒダン
トインへのD−N−カルバモイルアミノ酸の混
入を防止する措置及び反応終了後残存するD−
N−カルバモイルアミノ酸を分取、ラセミ化す
るための煩雑な工程が全く不要となり、製造工
程が極めて単純化されると共に目的とするL−
アミノ酸を高収率で製造できるようになつた。
(3) DL−N−カルバモイルアミノ酸の水溶性塩
を原料として固定化菌体カラムを用いて反応を
行ない得るので、製造工程の連続化が容易であ
る。
(4) アルスロバクター エスピー DP−B−
1002株は活性が高いので、菌体活性を高めるた
めの活性のインデユーサーとなる物質を培養液
に添加する必要が全く不要な変異株であるた
め、これを用いた本発明方法は従来法に比べ培
養コストを大幅に低減し得ると共に培養管理を
簡略化でき工業的に非常に有利である。
〔実施例〕
次に参考例、実施例及び試験例を挙げて説明す
る。
参考例 1
アルスロバクター エスピー DP−B−1001
(微工研菌寄第8190号)株は、栃木県日光市の土
壌から以下の方法でスクリーニングを行なつた結
果単離された。
土壌約0.5gを減菌水5mlに懸濁し希釈した後
トリプトソイ寒天平板上に塗布し、28℃にて培養
を行つて菌を得た。このようにして得た菌をグル
コース10g/、酵母エキス5g/、ポリペプ
トン5g/、肉エキス2g/、MgSO4・
7H2O0.4g/、FeSO4・7H2O0.01g/、
MnSO4・5H2O0.01g/から成りPHを7.0に調節
した液体培地に接種し、28℃2日間振とう培地を
行ない菌体を得た。菌体は10g/のN−カルバ
モイルアミノ酸(例えばDL−N−カルバモイル
トリプトフアン)又は5置換ヒダントイン(例え
ばDL−5−インドリルメチルヒダントイン)を
含む0.2Mアンモニウム緩衝液(PH9.0)に添加
し、37℃に24時間保温した。保温後緩衝液上清中
のL−アミノ酸をロイコノストツク・メゼンテロ
イデスP−60を用いたバイオアツセイ法及びシリ
カゲルプレートによる薄層クロマトグラフイーに
より測定した所、特に高いアミノ酸生成活性を与
えた菌株として本菌が得られた。
実施例 1
アルスロバクター エスピー DP−B−1002
株は、参考例1で得た同DP−B−1001株の変異
株で以下の方法により単離されたものである。
DP−B−1001株を参考例1で用いたものと同
じ液体培地に1mg/mlのp−ジメチルアミノベン
ゼンジアゾスルホン酸ナトリウムを加えた液体培
地にて培養した後トリプトソン寒天平板上に塗布
し、28℃にて培養を行つて菌を得、参考例1と同
様の方法によりアミノ酸生成活性を測定し、非常
に高いアミノ酸生成活性を与えた変異株として本
菌を得た。
試験例 1
(1) 種菌の培養、菌体作成
参考例1で用いたものと同じ液体培地を500ml
容三角フラスコに200ml分注し、減菌後実施例1
で得たアルスロバクター エスピー DP−B−
1002株を接種し、28℃で72時間振とう培養した。
培養液から18000G10分間の遠心により菌体を集
め、生理食塩水により1回洗浄し、湿菌体を得、
酵素反応に用いる洗浄菌体とした。
(2) 酵素反応
(1)で得られた洗浄菌体10gを精製水50mlに懸濁
したものに、0.8MNH4OH−Cl(PH8.0)、4mM
FeSO4・7H2O及び4mM MnSO4・5H2Oなる組
成の緩衝液25mlを加え、更に原料としてD−N
−カルバモイルフエニルアラニン200g/、
D−N−カルバモイル3−0−メチルドーパ20
g/、D−N−カルバモイルチロシン20g/
、D−N−カルバモイルトリプトフアン20
g/、D−N−カルバモイルメチオニン20
g/、D−N−カルバモイルバリン20g/
、D−N−カルバモイルロイシン20g/の
各ナトリウム塩溶液25mlを加え、N2気流を吹き
込み、37℃に48時間保温した。
反応終了後、菌体を遠心分離により除き、遠心
上清中のアミノ酸を日立638−50型、反応型液体
クロマトグラフイー(カラム:日立ゲルNo.2619、
4mmφ×150mm、溶出液:クエン酸ナトリウム緩
衝液0.4ml/分、アツセイ;ニンヒドリン反応
570nm)及びロイコノストツクメゼンテロイデス
を用いたバイオアツセイ法にて定量したところ、
次の第1表に示す量のL−アミノ酸が蓄積してい
た。
Arthrobacter sp. DP- of the present invention
B-1002 contains 5-substituted hydantoin and N-carbamoyl amino acid as D-form and L-form as shown in the test example below.
Each corresponding L regardless of body or DL body
-Has the effect of converting into amino acids. [Effects of the Invention] Since the novel microorganism of the present invention has the above-mentioned abilities, if it is used in the production of L-amino acids, the productivity can be dramatically improved. That is, (1) D-N-carbamoyl amino acids, which could not be used due to the lack of suitable microorganisms, can also be treated with the corresponding L.
-Can be used as a starting material for amino acid production. (2) Since there is no need to remove DL-N-carbamoyl amino acid, which is a by-product when chemically producing 5-substituted hydantoin, from the reaction system, DL-5-substituted hydantoin and DL can be easily and inexpensively obtained industrially. L-amino acids can be quantitatively produced from a mixture of -N-carbamoyl amino acids in a single reaction. Therefore, measures to prevent the contamination of DN-carbamoyl amino acids into DL-5-substituted hydantoins, which were necessary in the conventional L-amino acid production process using DL-5-substituted hydantoins as a starting material, and those remaining after the completion of the reaction. D-
The complicated process of separating and racemizing N-carbamoyl amino acids is completely unnecessary, and the manufacturing process is extremely simplified and the desired L-
It has become possible to produce amino acids with high yield. (3) Since the reaction can be carried out using a water-soluble salt of DL-N-carbamoyl amino acid as a raw material using an immobilized cell column, the production process can be easily made continuous. (4) Arthrobacter sp. DP-B-
Since the 1002 strain is highly active, it is a mutant strain that does not require the addition of a substance that acts as an inducer of activity to the culture solution to increase cell activity, so the method of the present invention using this strain is different from the conventional method. In comparison, culture costs can be significantly reduced and culture management can be simplified, which is very advantageous from an industrial perspective. [Example] Next, reference examples, working examples, and test examples will be given and explained. Reference example 1 Arthrobacter sp. DP-B-1001
(Feikoken Bacteria No. 8190) strain was isolated from the soil of Nikko City, Tochigi Prefecture as a result of screening using the following method. Approximately 0.5 g of soil was suspended in 5 ml of sterilized water, diluted, spread on a trypto-soy agar plate, and cultured at 28°C to obtain bacteria. The bacteria thus obtained were mixed with glucose 10g/, yeast extract 5g/, polypeptone 5g/, meat extract 2g/, MgSO4 .
7H 2 O0.4g/, FeSO 4・7H 2 O0.01g/,
It was inoculated into a liquid medium containing 0.01 g of MnSO 4 .5H 2 O and adjusted to pH 7.0, and cultured with shaking at 28° C. for 2 days to obtain bacterial cells. The bacterial cells were added to a 0.2 M ammonium buffer (PH 9.0) containing 10 g/N-carbamoyl amino acid (e.g. DL-N-carbamoyltryptophan) or 5-substituted hydantoin (e.g. DL-5-indolylmethylhydantoin). and kept at 37°C for 24 hours. After incubation, L-amino acids in the buffer supernatant were measured by bioassay using Leuconostoc mesenteroides P-60 and thin layer chromatography using silica gel plates, and this strain was found to have particularly high amino acid production activity. Obtained. Example 1 Arthrobacter sp. DP-B-1002
The strain is a mutant strain of the same DP-B-1001 strain obtained in Reference Example 1, and was isolated by the following method. Strain DP-B-1001 was cultured in the same liquid medium as used in Reference Example 1 plus 1 mg/ml of sodium p-dimethylaminobenzenediazosulfonate, and then spread on a tryptoson agar plate. A bacterium was obtained by culturing at 28°C, and the amino acid production activity was measured in the same manner as in Reference Example 1, and the present bacterium was obtained as a mutant strain that had extremely high amino acid production activity. Test example 1 (1) Cultivation of inoculum, preparation of bacterial cells 500 ml of the same liquid medium used in Reference example 1
Dispense 200ml into a Erlenmeyer flask and sterilize it.Example 1
Arthrobacter sp. DP-B- obtained from
1002 strain was inoculated and cultured with shaking at 28°C for 72 hours.
Collect bacterial cells from the culture solution by centrifugation at 18,000G for 10 minutes, wash once with physiological saline to obtain wet bacterial cells,
This was used as washed bacterial cells for use in enzyme reactions. (2) Enzyme reaction Suspend 10g of washed bacterial cells obtained in (1) in 50ml of purified water, add 0.8MNH 4 OH-Cl (PH8.0), 4mM
Add 25 ml of a buffer solution containing FeSO 4 .7H 2 O and 4mM MnSO 4 .5H 2 O, and add D-N as a raw material.
-Carbamoylphenylalanine 200g/,
D-N-carbamoyl 3-0-methyldopa 20
g/, D-N-carbamoyltyrosine 20g/
, D-N-carbamoyl tryptophan 20
g/, D-N-carbamoylmethionine 20
g/, D-N-carbamoylvaline 20g/
, 20 g of DN-carbamoylleucine/25 ml of each sodium salt solution were added thereto, a stream of N 2 was blown into the mixture, and the mixture was kept at 37° C. for 48 hours. After the reaction, the bacterial cells were removed by centrifugation, and the amino acids in the centrifuged supernatant were analyzed using Hitachi Model 638-50, reactive liquid chromatography (column: Hitachi Gel No. 2619,
4mmφ×150mm, eluent: sodium citrate buffer 0.4ml/min, assay: ninhydrin reaction
570nm) and a bioassay method using Leuconostocmesenteroides,
L-amino acids were accumulated in the amounts shown in Table 1 below.
【表】
* アミノ酸分析計による測定値。
試験例 2
試験例1の(1)と同様にして得られたDP−B−
1002株の洗浄菌体10gを精製水50mlに懸濁したも
のに、0.4MNH4Cl−NH4OH(PH9.0)、2mM
FeSO・7H2O及び2mM MnSO4・5H2Oなる組
成の緩衝液50mlを加え100mlとした。これにDL
−5−ベンジルヒダントイン10g、DL−5−
(3′−メトキシ−4′−ヒドロキシベンジル)ヒダ
ントイン10g、DL−5−(4′ヒドロキシベンジ
ル)ヒダントイン1g、〓DL−5−インドリル
メチルヒダントイン1g、〓DL−5−メチルメ
ルカプトエチルヒダトイン1g、〓DL−5−イ
ソプロピルヒダントイン1g、〓DL−5−イソ
ブチルヒダントイン1gをそれぞれ懸濁し、N2
気流を吹き込み、37℃に48時間保温した。
反応終了後、菌体を遠心分離により除き、遠心
上清中のアミノ酸を試験例1と同様にして定量し
たところ、次の第2表に示す量のL−アミノ酸が
蓄積していた。[Table] *Measured values using an amino acid analyzer.
Test Example 2 DP-B- obtained in the same manner as Test Example 1 (1)
10g of washed bacterial cells of strain 1002 were suspended in 50ml of purified water, and 0.4MNH4Cl - NH4OH (PH9.0), 2mM
50 ml of a buffer solution having a composition of FeSO.7H 2 O and 2mM MnSO 4.5H 2 O was added to make 100 ml. DL for this
-5-Benzylhydantoin 10g, DL-5-
(3'-methoxy-4'-hydroxybenzyl)hydantoin 10g, DL-5-(4'hydroxybenzyl)hydantoin 1g, DL-5-indolylmethylhydantoin 1g, DL-5-methylmercaptoethylhydatoin 1g , 1 g of DL-5-isopropylhydantoin, and 1 g of DL-5-isobutylhydantoin were suspended in N 2
It was kept at 37°C for 48 hours with a stream of air. After the reaction was completed, the bacterial cells were removed by centrifugation, and the amino acids in the centrifuged supernatant were quantified in the same manner as in Test Example 1. As a result, L-amino acids were accumulated in the amounts shown in Table 2 below.
【表】
* 第1表と同じ。
試験例 3
グルコース10g/、コーンステイープリカー
20g/を含有する培地をPH7.0に調整し、3
容ミニジヤーフアーメンターに2分注し、アル
スロバクター エスピー DP−B−1002株を接
種し、1/分の通気、700rpmの攪拌下、28℃
で36時間培養した。培養終了後、遠心により菌体
を集め、78gの湿菌体を得た。
上記湿菌体を800mlの精製水に懸濁し、1.2nM
の酢酸コバルト溶液400mlと80g/のDL−N−
カルバモイルフエニルアラニン400mlを加え、N2
気流吹き込み下、PHを塩酸とアンモニアで6.7に
調整しつつ37℃に22時間保温した。反応終了後、
菌体は遠心により回収し、再び上記反応液作成方
法に従い新たな反応に用いた。
以上の操作を7回にわたつて行つた結果、下表
に記す量のL−フエニルアラニンを含む上清液が
得られた。[Table] * Same as Table 1.
Test example 3 Glucose 10g/, cornstarch liquor
A medium containing 20g/adjusted to pH 7.0,
Arthrobacter sp. DP-B-1002 strain was inoculated into a mini jar fermenter, and the mixture was heated at 28°C under aeration of 1/min and stirring at 700 rpm.
The cells were cultured for 36 hours. After the culture was completed, the cells were collected by centrifugation to obtain 78 g of wet cells. Suspend the above wet bacterial cells in 800ml of purified water and add 1.2nM
400ml of cobalt acetate solution and 80g/DL-N-
Add 400ml of carbamoylphenylalanine, N2
The temperature was maintained at 37°C for 22 hours while the pH was adjusted to 6.7 with hydrochloric acid and ammonia under air flow. After the reaction is complete,
The bacterial cells were collected by centrifugation and used again in a new reaction according to the reaction solution preparation method described above. As a result of performing the above operation seven times, a supernatant containing L-phenylalanine in the amount shown in the table below was obtained.
【表】
試験例 4
グルコース10g/、コーンステイプリカー20
g/、DL−5−インドリルメチルヒダントイ
ン1.5g/を含有するPH7.0の培地を3容ミニ
ジヤーフアーメンターに2仕込み、アルスロバ
クター エスピー DP−B−1001株を接種し、
別にグルコース10g/、コーンステイープリカ
ー20g/を含有するPH7.0の培地に、同様にア
ルスロバクター エスピー DP−B−1002株を
接種した。そして、各々のミニジヤーフアーメン
ターを1/分の通気、700rpmの攪拌のもと、
28℃、40時間の培養を行つた。培養液50mlから遠
心により菌体を集め、生理食塩水で洗浄し、各々
の洗浄菌体を得た。
反応は、50g/DL−5ベンジルヒダントイ
ン、1mM FeSO4・7H2O、1mM MnSO4・5H2
O、0.2M NH4Cl−NH4OH(PH9.0)を含有する
反応液10mm及び50g/D−N−カルバモイルフ
エニルアラニン、1mM FeSO4・7H2O、1mM
MnSO4・5H2O、0.2M NH4Cl−NH4OH(PH
8.0)を含有する反応液10mlの2種類の反応液を
調製し、DP−B−1001株又はDP−B−1002株の
上記洗浄菌体を各々等量ずつ加えて密栓をし、37
℃に24時間保温して行つた。
反応終了後、遠心により菌体を除き、上清液を
得、含まれるL−フエニルアラニンを定量した。
その結果を第4表に示す。
第4表から、DP−B−1002株の方が活性が高
いことが判る。[Table] Test example 4 Glucose 10g/, corn staple liquor 20
Two 3-volume mini-jar fermenters were charged with PH7.0 culture medium containing 1.5 g/g/DL-5-indolylmethylhydantoin, and Arthrobacter sp. DP-B-1001 strain was inoculated.
Separately, Arthrobacter sp. DP-B-1002 strain was similarly inoculated into a pH 7.0 medium containing 10 g/g of glucose and 20 g/20 g of corn staple liquor. Then, each mini-jar fermenter was aerated for 1/min and stirred at 700 rpm.
Culture was performed at 28°C for 40 hours. Bacterial cells were collected from 50 ml of the culture solution by centrifugation and washed with physiological saline to obtain each washed bacterial cell. The reaction was carried out using 50g/DL-5 benzylhydantoin, 1mM FeSO 4 7H 2 O, 1mM MnSO 4 5H 2
10 mm and 50 g of reaction solution containing O, 0.2M NH4Cl - NH4OH (PH9.0)/D-N-carbamoylphenylalanine, 1mM FeSO4.7H2O , 1mM
MnSO 4・5H 2 O, 0.2M NH 4 Cl−NH 4 OH (PH
Prepare two types of reaction solutions (10 ml each) containing 8.0), add an equal amount of the above-mentioned washed bacterial cells of DP-B-1001 strain or DP-B-1002 strain, and seal tightly.
It was kept warm at ℃ for 24 hours. After the reaction was completed, the bacterial cells were removed by centrifugation to obtain a supernatant, and the L-phenylalanine contained therein was quantified.
The results are shown in Table 4. From Table 4, it can be seen that the DP-B-1002 strain has higher activity.
Claims (1)
イン及びN−カルバモイルアミノ酸を対応するそ
れぞれのL−アミノ酸に転換する能力を有する新
菌種アルスロバクター エスピー DP−B−
1002(微工研菌寄第8191号)。1. A new bacterial species, Arthrobacter sp. DP-B-, which belongs to the genus Arthrobacter and has the ability to convert 5-substituted hydantoins and N-carbamoyl amino acids into their respective L-amino acids.
1002 (Microtechnology Research Institute No. 8191).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14110685A JPS62271A (en) | 1985-06-27 | 1985-06-27 | Novel microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14110685A JPS62271A (en) | 1985-06-27 | 1985-06-27 | Novel microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62271A JPS62271A (en) | 1987-01-06 |
JPH0439316B2 true JPH0439316B2 (en) | 1992-06-29 |
Family
ID=15284315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14110685A Granted JPS62271A (en) | 1985-06-27 | 1985-06-27 | Novel microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62271A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4316928C2 (en) * | 1993-05-19 | 1995-03-16 | Degussa | New microorganisms, their use and process for the production of L-alpha-amino acids |
-
1985
- 1985-06-27 JP JP14110685A patent/JPS62271A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS62271A (en) | 1987-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0249188B1 (en) | Process for the production of L-2-amino-4-(hydroxymethyl-phosphinyl)-butyric acid | |
JPH0693839B2 (en) | Method for producing L-2-amino-4- (hydroxymethylphosphinyl) butyric acid | |
Tsugawa et al. | Production of l-Glutamic Acid from dl-Hydantoin-5-propionic Acid by Microoganisms: Part I. Screening of l-Glutamic Acid-Producing Microorganisms and Some Optimal Conditions for Production of l-Glutamic Acid | |
JP2950896B2 (en) | Method for producing D-α-phenylglycine | |
JPS6156086A (en) | Microbial preparation of alpha-hydroxyacid and its salt | |
JPH0552195B2 (en) | ||
JPH04365491A (en) | Production of 4-halo-3-hydroxybutylamide | |
JPH0439316B2 (en) | ||
JP2670838B2 (en) | Method for producing L-α-amino acids | |
JPH0669381B2 (en) | Carnitine manufacturing method | |
JPH051716B2 (en) | ||
JPH04222591A (en) | Production of s-(+)-mandelamide and derivative thereof | |
JPH04218385A (en) | Production of r(-)-mandelic acid | |
JP3117790B2 (en) | Method for producing L-α-aminoadipic acid | |
JPS58116690A (en) | Preparation of d-beta-hydroxyamino acid | |
JPH0439315B2 (en) | ||
JP3090761B2 (en) | Production method of optically active lactic acid | |
JP2899071B2 (en) | Method for producing L-α-alanine | |
JPH0591895A (en) | Production of d-serine | |
WO1996031616A1 (en) | Process for producing l-2-aminoadipic acid | |
JPH05176794A (en) | Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JPH02207793A (en) | Production of d-beta-hydroxyamino acid | |
JPS61173789A (en) | Production of 4-chloro-3-hydroxybutyric acid | |
JPH0438399B2 (en) | ||
JPH08154692A (en) | Production of d-2-aminobutyric acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |